• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示内分泌干扰化学物质对肥胖病理生理学途径的影响。

Unravelling the Influence of Endocrine-Disrupting Chemicals on Obesity Pathophysiology Pathways.

机构信息

LAQV, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.

UCIBIO, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.

出版信息

Adv Exp Med Biol. 2024;1460:883-918. doi: 10.1007/978-3-031-63657-8_30.

DOI:10.1007/978-3-031-63657-8_30
PMID:39287876
Abstract

Obesity represents a global health concern, affecting individuals of all age groups across the world. The prevalence of excess weight and obesity has escalated to pandemic proportions, leading to a substantial increase in the incidence of various comorbidities, such as cardiovascular diseases, type 2 diabetes, and cancer. This chapter seeks to provide a comprehensive exploration of the pathways through which endocrine-disrupting chemicals can influence the pathophysiology of obesity. These mechanisms encompass aspects such as the regulation of food intake and appetite, intestinal fat absorption, lipid metabolism, and the modulation of inflammation. This knowledge may help to elucidate the role of exogenous molecules in both the aetiology and progression of obesity.

摘要

肥胖是一个全球性的健康问题,影响着世界各地各个年龄段的人。超重和肥胖的流行已经达到了大流行的程度,导致各种合并症的发病率显著增加,如心血管疾病、2 型糖尿病和癌症。本章旨在全面探讨内分泌干扰物如何影响肥胖的病理生理学途径。这些机制包括调节食物摄入和食欲、肠道脂肪吸收、脂代谢和炎症调节等方面。这些知识可能有助于阐明外源性分子在肥胖的病因和进展中的作用。

相似文献

1
Unravelling the Influence of Endocrine-Disrupting Chemicals on Obesity Pathophysiology Pathways.揭示内分泌干扰化学物质对肥胖病理生理学途径的影响。
Adv Exp Med Biol. 2024;1460:883-918. doi: 10.1007/978-3-031-63657-8_30.
2
Environmental Obesogens: Mechanisms and Controversies.环境内分泌干扰物:作用机制与争议
Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:89-106. doi: 10.1146/annurev-pharmtox-010818-021304. Epub 2018 Jul 25.
3
Obesogens and Energy Homeostasis: Definition, Mechanisms of Action, Exposure, and Adverse Effects on Human Health.致肥胖物与能量稳态:定义、作用机制、暴露情况及对人类健康的不良影响
Neuroendocrinology. 2025;115(1):72-100. doi: 10.1159/000542901. Epub 2024 Dec 2.
4
Obesogens.肥胖素
Curr Opin Endocrinol Diabetes Obes. 2010 Oct;17(5):453-9. doi: 10.1097/MED.0b013e32833ddea0.
5
Role of Obesogens in the Pathogenesis of Obesity.肥胖成因中的环境内分泌干扰物作用
Medicina (Kaunas). 2019 Aug 21;55(9):515. doi: 10.3390/medicina55090515.
6
Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling.环境致肥胖物:有机锡与通过核受体信号传导的内分泌干扰
Endocrinology. 2006 Jun;147(6 Suppl):S50-5. doi: 10.1210/en.2005-1129. Epub 2006 May 11.
7
Obesogens in Foods.食品中的致肥胖物。
Biomolecules. 2022 May 9;12(5):680. doi: 10.3390/biom12050680.
8
Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action.肥胖诱导物:它们的鉴定方法及作用的分子机制。
Front Endocrinol (Lausanne). 2021 Nov 25;12:780888. doi: 10.3389/fendo.2021.780888. eCollection 2021.
9
Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.雌激素和雌激素类化学物质对能量代谢途径的调节及其与因接触内分泌干扰物增加而导致的肥胖的潜在关联。
Biochim Biophys Acta. 2009 Jul;1793(7):1128-43. doi: 10.1016/j.bbamcr.2009.03.009. Epub 2009 Apr 5.
10
Endocrine disruptors and obesity.内分泌干扰物与肥胖。
Nat Rev Endocrinol. 2015 Nov;11(11):653-61. doi: 10.1038/nrendo.2015.163. Epub 2015 Sep 22.

引用本文的文献

1
Endocrinology and Metabolic Diseases in Human Health.人类健康中的内分泌与代谢疾病
Nutrients. 2025 Mar 28;17(7):1175. doi: 10.3390/nu17071175.

本文引用的文献

1
Adipose Tissue Dynamics: Cellular and Lipid Turnover in Health and Disease.脂肪组织动力学:健康与疾病中的细胞和脂质周转。
Nutrients. 2023 Sep 14;15(18):3968. doi: 10.3390/nu15183968.
2
Molecular determinants of inhibition of UCP1-mediated respiratory uncoupling.UCP1 介导线粒体解偶联呼吸抑制的分子决定因素。
Nat Commun. 2023 May 5;14(1):2594. doi: 10.1038/s41467-023-38219-9.
3
White Adipose Tissue Dysfunction: Pathophysiology and Emergent Measurements.白色脂肪组织功能障碍:病理生理学与新兴检测方法。
Nutrients. 2023 Mar 31;15(7):1722. doi: 10.3390/nu15071722.
4
New insights into the role of dietary triglyceride absorption in obesity and metabolic diseases.饮食中甘油三酯吸收在肥胖和代谢性疾病中的作用的新见解。
Front Pharmacol. 2023 Feb 2;14:1097835. doi: 10.3389/fphar.2023.1097835. eCollection 2023.
5
Co-expression analysis of lncRNA and mRNA identifies potential adipogenesis regulatory non-coding RNAs involved in the transgenerational effects of tributyltin.长链非编码 RNA 和信使 RNA 的共表达分析鉴定了三丁基锡跨代效应中涉及脂肪生成调节的潜在非编码 RNA。
PLoS One. 2023 Feb 3;18(2):e0281240. doi: 10.1371/journal.pone.0281240. eCollection 2023.
6
Environmental endocrine disruptor Bisphenol A induces metabolic derailment and obesity via upregulating IL-17A in adipocytes.环境内分泌干扰物双酚A通过上调脂肪细胞中的白细胞介素-17A诱导代谢紊乱和肥胖。
Environ Int. 2023 Feb;172:107759. doi: 10.1016/j.envint.2023.107759. Epub 2023 Jan 16.
7
Mitochondrial Energy Metabolism in the Regulation of Thermogenic Brown Fats and Human Metabolic Diseases.线粒体能量代谢在调节产热棕色脂肪和人类代谢疾病中的作用。
Int J Mol Sci. 2023 Jan 10;24(2):1352. doi: 10.3390/ijms24021352.
8
Application of In Vitro Models for Studying the Mechanisms Underlying the Obesogenic Action of Endocrine-Disrupting Chemicals (EDCs) as Food Contaminants-A Review.体外模型在研究作为食品污染物的内分泌干扰化学物质(EDCs)致肥胖作用机制中的应用——综述。
Int J Mol Sci. 2023 Jan 5;24(2):1083. doi: 10.3390/ijms24021083.
9
Sleep Deprivation and Central Appetite Regulation.睡眠剥夺与中枢食欲调节。
Nutrients. 2022 Dec 7;14(24):5196. doi: 10.3390/nu14245196.
10
Mitochondrial Fatty Acid β-Oxidation Disorders: From Disease to Lipidomic Studies-A Critical Review.线粒体脂肪酸 β-氧化障碍:从疾病到脂质组学研究——综述。
Int J Mol Sci. 2022 Nov 11;23(22):13933. doi: 10.3390/ijms232213933.